Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLX2853 Monotherapy and Combination with Carboplatin in Gynecologic Malignancies
NCT04493619Phase 2Terminated
- Sponsor
- Opna Bio
- Start
- Aug 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of PLX2853 in gynecologic cancer, ovarian cancer, sponsored by Opna Bio. Started Aug 2020; status: terminated.
02
Drugs
PLX2853
03
Conditions
gynecologic cancerovarian cancer
Beyond the preview
Go deeper on NCT04493619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04493619.